1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hypersensitivity, Type III in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belovezhdov, N; Genova, V; Robeva, R | 1 |
| Willoughby, JB; Willoughby, WF | 1 |
| Jancar, S; Steil, AA; Tavares de Lima, W | 1 |
| Johnson, KJ; Ward, PA; Warren, JS | 1 |
| Johnson, KJ; Mandel, DM; Ward, PA; Warren, JS | 1 |
| Alberton, M; Camussi, G; Coda, R; Macchiorlatti, E; Mariano, F; Montrucchio, G; Mularoni, E; Roffinello, C; Tetta, C | 1 |
| Andres, G; Brentjens, J; Camussi, G; Pawlowski, I; Saunders, R | 1 |
| Barnes, JL; Venkatachalam, MA | 1 |
| Braquet, P; De Giaccobi, G; Jancar, S; Mariano, M; Mencia-Huerta, JM; Sirois, P | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypersensitivity, Type III
| Article | Year |
|---|---|
[Changes in blood coagulation in glomerulonephritis].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Glomerulus; Microcirculation; Platelet Activating Factor; Platelet Aggregation; Renal Circulation; Syndrome | 1982 |
Immunologic mechanisms of parenchymal lung injury.
Topics: Animals; Arachidonic Acids; Arthus Reaction; Autoimmune Diseases; Biotransformation; Complement System Proteins; Disease Models, Animal; Free Radicals; Humans; Immune Complex Diseases; Lung Diseases; Lymphokines; Platelet Activating Factor | 1984 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypersensitivity, Type III
| Article | Year |
|---|---|
Modulation by lipid mediators of immune complex-induced lung inflammation in mice.
Topics: Animals; Antigen-Antibody Complex; Arthus Reaction; Azepines; Benzopyrans; Blood Vessels; Bronchoalveolar Lavage Fluid; Capillary Permeability; Dose-Response Relationship, Drug; Eicosanoids; Hemoglobins; Immune Complex Diseases; Indoles; Indomethacin; Lipoxygenase Inhibitors; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pneumonia; Receptors, Leukotriene B4; Species Specificity; Triazoles | 1998 |
PAF and immune complex-induced injury.
Topics: Animals; Furans; Immune Complex Diseases; Lung Diseases; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Alveoli; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Vasculitis | 1990 |
Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat.
Topics: Animals; Capillary Permeability; Furans; Hydroxides; Hydroxyl Radical; Immune Complex Diseases; Lymphocyte Activation; Microscopy, Electron; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Rats; Vasculitis | 1989 |
The role of platelet-activating factor in experimental immune complex pathology.
Topics: Animals; Antigen-Antibody Complex; Blood Vessels; Capillary Permeability; Chemical and Drug Induced Liver Injury; Complement C3; Female; Heart Diseases; Immune Complex Diseases; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Platelet Activating Factor; Rabbits | 1985 |
Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
Topics: Animals; Arthus Reaction; Complement System Proteins; Female; Fluorescent Antibody Technique; Glomerulonephritis; Histocytochemistry; Immune Complex Diseases; Immunoglobulin G; Platelet Activating Factor; Rats; Rats, Inbred Lew; Thiazoles | 1987 |
The role of platelets and polycationic mediators in glomerular vascular injury.
Topics: Arteritis; Blood Platelets; Glomerular Filtration Rate; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Glomerulus; Platelet Activating Factor; Polyamines; Polyelectrolytes; Polymers | 1985 |
Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Diterpenes; Ginkgolides; Immune Complex Diseases; Lactones; Male; Pancreatitis; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1988 |